{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T02:11:03Z","timestamp":1791252663527,"version":"4.1.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2013,1,21]],"date-time":"2013-01-21T00:00:00Z","timestamp":1358726400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2013,1,21]],"date-time":"2013-01-21T00:00:00Z","timestamp":1358726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2014,1,30]]},"DOI":"10.1038\/onc.2012.632","type":"journal-article","created":{"date-parts":[[2013,1,21]],"date-time":"2013-01-21T12:35:37Z","timestamp":1358771737000},"page":"539-549","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":89,"title":["Aurora kinase A mediates epithelial ovarian cancer cell migration and adhesion"],"prefix":"10.1038","volume":"33","author":[{"given":"T-V","family":"Do","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L E","family":"Bickel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A J","family":"Klein-Szanto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H B","family":"Pathak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Howe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S W","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Maglaty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J A","family":"Ecsedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Litwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E A","family":"Golemis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R J","family":"Schilder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A K","family":"Godwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D C","family":"Connolly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,1,21]]},"reference":[{"key":"BFonc2012632_CR1","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3322\/CA.2007.0010","volume":"58","author":"A Jemal","year":"2008","unstructured":"Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T et al. Cancer statistics, 2008. CA Cancer J Clin 2008; 58: 71\u201396.","journal-title":"CA Cancer J Clin"},{"key":"BFonc2012632_CR2","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1158\/1078-0432.CCR-07-2179","volume":"14","author":"O Gautschi","year":"2008","unstructured":"Gautschi O, Heighway J, Mack PC, Purnell PR, Lara PN, Gandara DR . Aurora kinases as anticancer drug targets. Clin Cancer Res 2008; 14: 1639\u20131648.","journal-title":"Clin Cancer Res"},{"key":"BFonc2012632_CR3","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1038\/nrc1502","volume":"4","author":"N Keen","year":"2004","unstructured":"Keen N, Taylor S . Aurora-kinase inhibitors as anticancer agents. Nat Rev Cancer 2004; 4: 927\u2013936.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2012632_CR4","doi-asserted-by":"publisher","first-page":"51786","DOI":"10.1074\/jbc.M306275200","volume":"278","author":"T Marumoto","year":"2003","unstructured":"Marumoto T, Honda S, Hara T, Nitta M, Hirota T, Kohmura E et al. Aurora-A kinase maintains the fidelity of early and late mitotic events in HeLa cells. J Biol Chem 2003; 278: 51786\u201351795.","journal-title":"J Biol Chem"},{"key":"BFonc2012632_CR5","first-page":"1420","volume":"9","author":"TM Gritsko","year":"2003","unstructured":"Gritsko TM, Coppola D, Paciga JE, Yang L, Sun M, Shelley SA et al. Activation and overexpression of centrosome kinase BTAK\/Aurora-A in human ovarian cancer. Clin Cancer Res 2003; 9: 1420\u20131426.","journal-title":"Clin Cancer Res"},{"key":"BFonc2012632_CR6","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1002\/ijc.20633","volume":"113","author":"LC Hsu","year":"2005","unstructured":"Hsu LC, Kapali M, DeLoia JA, Gallion HH . Centrosome abnormalities in ovarian cancer. Int J Cancer 2005; 113: 746\u2013751.","journal-title":"Int J Cancer"},{"key":"BFonc2012632_CR7","doi-asserted-by":"publisher","first-page":"4083","DOI":"10.1158\/1078-0432.CCR-06-2775","volume":"13","author":"S Lassmann","year":"2007","unstructured":"Lassmann S, Shen Y, Jutting U, Wiehle P, Walch A, Gitsch G et al. Predictive value of Aurora-A\/STK15 expression for late stage epithelial ovarian cancer patients treated by adjuvant chemotherapy. Clin Cancer Res 2007; 13: 4083\u20134091.","journal-title":"Clin Cancer Res"},{"key":"BFonc2012632_CR8","first-page":"1833","volume":"6","author":"MM Tanner","year":"2000","unstructured":"Tanner MM, Grenman S, Koul A, Johannsson O, Meltzer P, Pejovic T et al. Frequent amplification of chromosomal region 20q12-q13 in ovarian cancer. Clin Cancer Res 2000; 6: 1833\u20131839.","journal-title":"Clin Cancer Res"},{"key":"BFonc2012632_CR9","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1002\/mc.20098","volume":"43","author":"CM Chung","year":"2005","unstructured":"Chung CM, Man C, Jin Y, Jin C, Guan XY, Wang Q et al. Amplification and overexpression of aurora kinase A (AURKA) in immortalized human ovarian epithelial (HOSE) cells. Mol Carcinog 2005; 43: 165\u2013174.","journal-title":"Mol Carcinog"},{"key":"BFonc2012632_CR10","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3727\/096504005775082101","volume":"15","author":"W Hu","year":"2005","unstructured":"Hu W, Kavanagh JJ, Deaver M, Johnston DA, Freedman RS, Verschraegen CF et al. Frequent overexpression of STK15\/Aurora-A\/BTAK and chromosomal instability in tumorigenic cell cultures derived from human ovarian cancer. Oncol Res 2005; 15: 49\u201357.","journal-title":"Oncol Res"},{"key":"BFonc2012632_CR11","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ygyno.2010.09.003","volume":"120","author":"H Lassus","year":"2011","unstructured":"Lassus H, Staff S, Leminen A, Isola J, Butzow R . Aurora-A overexpression and aneuploidy predict poor outcome in serous ovarian carcinoma. Gynecol Oncol 2011; 120: 11\u201317.","journal-title":"Gynecol Oncol"},{"key":"BFonc2012632_CR12","doi-asserted-by":"publisher","first-page":"4098","DOI":"10.1158\/1078-0432.CCR-07-0431","volume":"13","author":"CN Landen","year":"2007","unstructured":"Landen CN, Lin YG, Immaneni A, Deavers MT, Merritt WM, Spannuth WA et al. Overexpression of the centrosomal protein Aurora-A kinase is associated with poor prognosis in epithelial ovarian cancer patients. Clin Cancer Res 2007; 13: 4098\u20134104.","journal-title":"Clin Cancer Res"},{"key":"BFonc2012632_CR13","doi-asserted-by":"publisher","first-page":"10436","DOI":"10.1158\/0008-5472.CAN-07-1379","volume":"67","author":"Z Guan","year":"2007","unstructured":"Guan Z, Wang XR, Zhu XF, Huang XF, Xu J, Wang LH et al. Aurora-A, a negative prognostic marker, increases migration and decreases radiosensitivity in cancer cells. Cancer Res 2007; 67: 10436\u201310444.","journal-title":"Cancer Res"},{"key":"BFonc2012632_CR14","doi-asserted-by":"publisher","first-page":"5136","DOI":"10.1158\/1078-0432.CCR-05-1650","volume":"12","author":"R Reiter","year":"2006","unstructured":"Reiter R, Gais P, Jutting U, Steuer-Vogt MK, Pickhard A, Bink K et al. Aurora kinase A messenger RNA overexpression is correlated with tumor progression and shortened survival in head and neck squamous cell carcinoma. Clin Cancer Res 2006; 12: 5136\u20135141.","journal-title":"Clin Cancer Res"},{"key":"BFonc2012632_CR15","doi-asserted-by":"publisher","first-page":"7304","DOI":"10.1158\/1078-0432.CCR-04-0806","volume":"10","author":"T Tong","year":"2004","unstructured":"Tong T, Zhong Y, Kong J, Dong L, Song Y, Fu M et al. Overexpression of Aurora-A contributes to malignant development of human esophageal squamous cell carcinoma. Clin Cancer Res 2004; 10: 7304\u20137310.","journal-title":"Clin Cancer Res"},{"key":"BFonc2012632_CR16","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1093\/carcin\/bgn176","volume":"29","author":"XB Wan","year":"2008","unstructured":"Wan XB, Long ZJ, Yan M, Xu J, Xia LP, Liu L et al. Inhibition of Aurora-A suppresses epithelial-mesenchymal transition and invasion by down-regulating MAPK in nasopharyngeal carcinoma cells. Carcinogenesis 2008; 29: 1930\u20131937.","journal-title":"Carcinogenesis"},{"key":"BFonc2012632_CR17","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s00405-011-1629-4","volume":"269","author":"H Zhang","year":"2012","unstructured":"Zhang H, Chen X, Jin Y, Liu B, Zhou L . Overexpression of Aurora-A promotes laryngeal cancer progression by enhancing invasive ability and chromosomal instability. Eur Arch Otorhinolaryngol 2012; 269: 607\u2013614.","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"BFonc2012632_CR18","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1093\/carcin\/bgn176","volume":"29","author":"XB Wan","year":"2008","unstructured":"Wan XB, Long ZJ, Yan M, Xu J, Xia LP, Liu L et al. Inhibition of Aurora-A suppresses epithelial-mesenchymal transition and invasion by downregulating MAPK in nasopharyngeal carcinoma cells. Carcinogenesis 2008; 29: 1930\u20131937.","journal-title":"Carcinogenesis"},{"key":"BFonc2012632_CR19","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/sj.onc.1208293","volume":"24","author":"M Tatsuka","year":"2005","unstructured":"Tatsuka M, Sato S, Kitajima S, Suto S, Kawai H, Miyauchi M et al. Overexpression of Aurora-A potentiates HRAS-mediated oncogenic transformation and is implicated in oral carcinogenesis. Oncogene 2005; 24: 1122\u20131127.","journal-title":"Oncogene"},{"key":"BFonc2012632_CR20","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1002\/ijc.22154","volume":"119","author":"H Yang","year":"2006","unstructured":"Yang H, He L, Kruk P, Nicosia SV, Cheng JQ . Aurora-A induces cell survival and chemoresistance by activation of Akt through a p53-dependent manner in ovarian cancer cells. Int J Cancer 2006; 119: 2304\u20132312.","journal-title":"Int J Cancer"},{"key":"BFonc2012632_CR21","doi-asserted-by":"publisher","first-page":"9013","DOI":"10.1074\/jbc.M411068200","volume":"280","author":"JC Wu","year":"2005","unstructured":"Wu JC, Chen TY, Yu CT, Tsai SJ, Hsu JM, Tang MJ et al. Identification of V23RalA-Ser194 as a critical mediator for Aurora-A-induced cellular motility and transformation by small pool expression screening. J Biol Chem 2005; 280: 9013\u20139022.","journal-title":"J Biol Chem"},{"key":"BFonc2012632_CR22","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/nrc1366","volume":"4","author":"TJ Yeatman","year":"2004","unstructured":"Yeatman TJ . A renaissance for SRC. Nat Rev Cancer 2004; 4: 470\u2013480.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2012632_CR23","doi-asserted-by":"publisher","first-page":"8975","DOI":"10.1158\/0008-5472.CAN-07-1328","volume":"67","author":"GM O\u2019Neill","year":"2007","unstructured":"O\u2019Neill GM, Seo S, Serebriiskii IG, Lessin SR, Golemis EA . A new central scaffold for metastasis: parsing HEF1\/Cas-L\/NEDD9. Cancer Res 2007; 67: 8975\u20138979.","journal-title":"Cancer Res"},{"key":"BFonc2012632_CR24","doi-asserted-by":"publisher","first-page":"384","DOI":"10.4161\/cc.5.4.2439","volume":"5","author":"EN Pugacheva","year":"2006","unstructured":"Pugacheva EN, Golemis EA . HEF1-aurora A interactions: points of dialog between the cell cycle and cell attachment signaling networks. Cell Cycle 2006; 5: 384\u2013391.","journal-title":"Cell Cycle"},{"key":"BFonc2012632_CR25","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/nature06030","volume":"448","author":"H Ji","year":"2007","unstructured":"Ji H, Ramsey MR, Hayes DN, Fan C, McNamara K, Kozlowski P et al. LKB1 modulates lung cancer differentiation and metastasis. Nature 2007; 448: 807\u2013810.","journal-title":"Nature"},{"key":"BFonc2012632_CR26","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/j.cell.2006.06.008","volume":"125","author":"M Kim","year":"2006","unstructured":"Kim M, Gans JD, Nogueira C, Wang A, Paik JH, Feng B et al. Comparative oncogenomics identifies NEDD9 as a melanoma metastasis gene. Cell 2006; 125: 1269\u20131281.","journal-title":"Cell"},{"key":"BFonc2012632_CR27","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/ncb1309","volume":"7","author":"EN Pugacheva","year":"2005","unstructured":"Pugacheva EN, Golemis EA . The focal adhesion scaffolding protein HEF1 regulates activation of the Aurora-A and Nek2 kinases at the centrosome. Nat Cell Biol 2005; 7: 937\u2013946.","journal-title":"Nat Cell Biol"},{"key":"BFonc2012632_CR28","doi-asserted-by":"publisher","first-page":"199","DOI":"10.2174\/1568026053507651","volume":"5","author":"A Mortlock","year":"2005","unstructured":"Mortlock A, Keen NJ, Jung FH, Heron NM, Foote KM, Wilkinson R et al. Progress in the development of selective inhibitors of Aurora kinases. Curr Top Med Chem 2005; 5: 199\u2013213.","journal-title":"Curr Top Med Chem"},{"key":"BFonc2012632_CR29","doi-asserted-by":"publisher","first-page":"4106","DOI":"10.1073\/pnas.0608798104","volume":"104","author":"MG Manfredi","year":"2007","unstructured":"Manfredi MG, Ecsedy JA, Meetze KA, Balani SK, Burenkova O, Chen W et al. Antitumor activity of MLN8054, an orally active small-molecule inhibitor of Aurora A kinase. Proc Natl Acad Sci USA 2007; 104: 4106\u20134111.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2012632_CR30","doi-asserted-by":"publisher","first-page":"7614","DOI":"10.1158\/1078-0432.CCR-11-1536","volume":"17","author":"MG Manfredi","year":"2011","unstructured":"Manfredi MG, Ecsedy JA, Chakravarty A, Silverman L, Zhang M, Hoar KM et al. Characterization of Alisertib (MLN8237), an investigational small-molecule inhibitor of aurora A kinase using novel in vivo pharmacodynamic assays. Clin Cancer Res 2011; 17: 7614\u20137624.","journal-title":"Clin Cancer Res"},{"key":"BFonc2012632_CR31","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s00018-009-0213-1","volume":"67","author":"N Tikhmyanova","year":"2010","unstructured":"Tikhmyanova N, Little JL, Golemis EA . CAS proteins in normal and pathological cell growth control. Cell Mol Life Sci 2010; 67: 1025\u20131048.","journal-title":"Cell Mol Life Sci"},{"key":"BFonc2012632_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.critrevonc.2008.12.003","volume":"72","author":"A Feki","year":"2009","unstructured":"Feki A, Berardi P, Bellingan G, Major A, Krause KH, Petignat P et al. Dissemination of intraperitoneal ovarian cancer: Discussion of mechanisms and demonstration of lymphatic spreading in ovarian cancer model. Crit Rev Oncol Hematol 2009; 72: 1\u20139.","journal-title":"Crit Rev Oncol Hematol"},{"key":"BFonc2012632_CR33","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/jcp.22011","volume":"223","author":"M Guarino","year":"2010","unstructured":"Guarino M . Src signaling in cancer invasion. J Cell Physiol 2010; 223: 14\u201326.","journal-title":"J Cell Physiol"},{"key":"BFonc2012632_CR34","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S1535-6108(02)00235-0","volume":"3","author":"S Anand","year":"2003","unstructured":"Anand S, Penrhyn-Lowe AR, Venkitaraman AR . Aurora-A amplificaiton overrides the mitotic spindle assembly checkpoint, inducing resistance to taxol. Cancer Cell 2003; 3: 51\u201362.","journal-title":"Cancer Cell"},{"key":"BFonc2012632_CR35","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1158\/0008-5472.CAN-04-3981","volume":"65","author":"T Hata","year":"2005","unstructured":"Hata T, Furukawa T, Sunamura M, Egawa S, Motoi F, Ohmura N et al. RNA interference targeting aurora kinase a suppresses tumor growth and enhances the taxane chemosensitivity in human pancreatic cancer cells. Cancer Res 2005; 65: 2899\u20132905.","journal-title":"Cancer Res"},{"key":"BFonc2012632_CR36","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1002\/hed.21007","volume":"31","author":"A Mazumdar","year":"2009","unstructured":"Mazumdar A, Henderson YC, El-Naggar AK, Sen S, Clayman GL . Aurora kinase A inhibition and paclitaxel as targeted combination therapy for head and neck squamous cell carcinoma. Head Neck 2009; 31: 625\u2013634.","journal-title":"Head Neck"},{"key":"BFonc2012632_CR37","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1158\/1535-7163.MCT-09-0609","volume":"9","author":"T Shimomura","year":"2010","unstructured":"Shimomura T, Hasako S, Nakatsuru Y, Mita T, Ichikawa K, Kodera T et al. MK-5108, a highly selective Aurora-A kinase inhibitor, shows antitumor activity alone and in combination with docetaxel. Mol Cancer Ther 2010; 9: 157\u2013166.","journal-title":"Mol Cancer Ther"},{"key":"BFonc2012632_CR38","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1158\/1078-0432.CCR-06-1192","volume":"13","author":"E Tanaka","year":"2007","unstructured":"Tanaka E, Hashimoto Y, Ito T, Kondo K, Higashiyama M, Tsunoda S et al. The suppression of aurora-A\/STK15\/BTAK expression enhances chemosensitivity to docetaxel in human esophageal squamous cell carcinoma. Clin Cancer Res 2007; 13: 1331\u20131340.","journal-title":"Clin Cancer Res"},{"key":"BFonc2012632_CR39","doi-asserted-by":"publisher","first-page":"876","DOI":"10.4161\/cc.8.6.7897","volume":"8","author":"DR Wysong","year":"2009","unstructured":"Wysong DR, Chakravarty A, Hoar K, Ecsedy JA . The inhibition of Aurora A abrogates the mitotic delay induced by microtubule perturbing agents. Cell Cycle 2009; 8: 876\u2013888.","journal-title":"Cell Cycle"},{"key":"BFonc2012632_CR40","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s00404-009-1121-1","volume":"281","author":"K Matsuo","year":"2010","unstructured":"Matsuo K, Eno ML, Im DD, Rosenshein NB . Chemotherapy time interval and development of platinum and taxane resistance in ovarian, fallopian, and peritoneal carcinomas. Arch Gynecol Obstet 2010; 281: 325\u2013328.","journal-title":"Arch Gynecol Obstet"},{"key":"BFonc2012632_CR41","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1124\/pr.58.3.10","volume":"58","author":"TC Chou","year":"2006","unstructured":"Chou TC . Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol Rev 2006; 58: 621\u2013681.","journal-title":"Pharmacol Rev"},{"key":"BFonc2012632_CR42","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.antiviral.2008.01.158","volume":"78","author":"KE Luker","year":"2008","unstructured":"Luker KE, Luker GD . Applications of bioluminescence imaging to antiviral research and therapy: multiple luciferase enzymes and quantitation. Antiviral Res 2008; 78: 179\u2013187.","journal-title":"Antiviral Res"},{"key":"BFonc2012632_CR43","doi-asserted-by":"publisher","first-page":"5437","DOI":"10.1158\/1078-0432.CCR-07-4922","volume":"14","author":"YG Lin","year":"2008","unstructured":"Lin YG, Immaneni A, Merritt WM, Mangala LS, Kim SW, Shahzad MM et al. Targeting aurora kinase with MK-0457 inhibits ovarian cancer growth. Clin Cancer Res 2008; 14: 5437\u20135446.","journal-title":"Clin Cancer Res"},{"key":"BFonc2012632_CR44","first-page":"262","volume":"10","author":"EA Harrington","year":"2004","unstructured":"Harrington EA, Bebbington D, Moore J, Rasmussen RK, Ajose-Adeogun AO, Nakayama T et al. VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo. Nature 2004; 10: 262\u2013267.","journal-title":"Nature"},{"key":"BFonc2012632_CR45","doi-asserted-by":"publisher","first-page":"9846","DOI":"10.1158\/0008-5472.CAN-10-3001","volume":"70","author":"M Payton","year":"2010","unstructured":"Payton M, Bush TL, Chung G, Ziegler B, Eden P, McElroy P et al. Preclinical evaluation of AMG 900, a novel potent and highly selective pan-aurora kinase inhibitor with activity in taxane-resistant tumor cell lines. Cancer Res 2010; 70: 9846\u20139854.","journal-title":"Cancer Res"},{"key":"BFonc2012632_CR46","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1158\/1078-0432.CCR-11-0999","volume":"18","author":"E Komlodi-Pasztor","year":"2012","unstructured":"Komlodi-Pasztor E, Sackett DL, Fojo AT . Inhibitors targeting mitosis: tales of how great drugs against a promising target were brought down by a flawed rationale. Clin Cancer Res 2012; 18: 51\u201363.","journal-title":"Clin Cancer Res"},{"key":"BFonc2012632_CR47","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1158\/1541-7786.MCR-09-0300","volume":"8","author":"JJ Huck","year":"2010","unstructured":"Huck JJ, Zhang M, McDonald A, Bowman D, Hoar KM, Stringer B et al. MLN8054, an inhibitor of Aurora A kinase, induces senescence in human tumor cells both in vitro and in vivo. Mol Cancer Res 2010; 8: 373\u2013384.","journal-title":"Mol Cancer Res"},{"key":"BFonc2012632_CR48","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1038\/onc.2011.314","volume":"31","author":"V Ratushny","year":"2012","unstructured":"Ratushny V, Pathak HB, Beeharry N, Tikhmyanova N, Xiao F, Li T et al. Dual inhibition of SRC and Aurora kinases induces postmitotic attachment defects and cell death. Oncogene 2012; 31: 1217\u20131227.","journal-title":"Oncogene"},{"key":"BFonc2012632_CR49","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/S1470-2045(06)70939-1","volume":"7","author":"DS Tan","year":"2006","unstructured":"Tan DS, Agarwal R, Kaye SB . Mechanisms of transcoelomic metastasis in ovarian cancer. Lancet Oncol 2006; 7: 925\u2013934.","journal-title":"Lancet Oncol"},{"key":"BFonc2012632_CR50","volume-title":"Current Protocols in Immunology","author":"S Swift","year":"2001","unstructured":"Swift S, Lorens J, Achacoso P, Nolan GP . Rapid Production of Retroviruses for Efficient Gene Delivery to Mammalian Cells Using 293T Cell\u2013Based Systems. Current Protocols in Immunology. John Wiley & Sons, Inc, 2001."},{"key":"BFonc2012632_CR51","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1158\/1541-7786.MCR-06-0319","volume":"5","author":"TV Do","year":"2007","unstructured":"Do TV, Symowicz JC, Berman DM, Liotta LA, Petricoin EF, Stack MS et al. Lysophosphatidic acid down-regulates stress fibers and up-regulates pro-matrix metalloproteinase-2 activation in ovarian cancer cells. Mol Cancer Res 2007; 5: 121\u2013131.","journal-title":"Mol Cancer Res"},{"key":"BFonc2012632_CR52","doi-asserted-by":"crossref","first-page":"14.2.1","DOI":"10.1002\/0471141755.ph1412s45","volume":"45","author":"DC Connolly","year":"2009","unstructured":"Connolly DC, Hensley HH . Xenograft and transgenic mouse models of epithelial ovarian cancer and non-invasive imaging modalities to monitor ovarian tumor growth in situ: applications in evaluating novel therapeutic agents. Curr Protoc Pharmacol 2009; 45: 14.2.1\u2013.2.36.","journal-title":"Curr Protoc Pharmacol"},{"key":"BFonc2012632_CR53","first-page":"1389","volume":"63","author":"DC Connolly","year":"2003","unstructured":"Connolly DC, Bao R, Nikitin AY, Stephens KC, Poole TW, Hua X et al. Female mice chimeric for expression of the simian virus 40 TAg under control of the MISIIR promoter develop epithelial ovarian cancer. Cancer Res 2003; 63: 1389\u20131397.","journal-title":"Cancer Res"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2012632.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2012632","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2012632.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,4]],"date-time":"2024-05-04T23:28:02Z","timestamp":1714865282000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2012632"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,21]]},"references-count":53,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,1,30]]}},"alternative-id":["BFonc2012632"],"URL":"https:\/\/doi.org\/10.1038\/onc.2012.632","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,21]]},"assertion":[{"value":"19 July 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2012","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2012","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2013","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}